UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 42

Sortiert nach

Antibody Response to HML‐2 May Be Protective in Amyotrophic Lateral Sclerosis

Annals of neurology, 2022-11, Vol.92 (5), p.782-792

2022

Link zum Volltext

Verfügbarkeit prüfen

Human Endogenous Retrovirus K Envelope in Spinal Fluid of Amyotrophic Lateral Sclerosis Is Toxic

Annals of neurology, 2022-10, Vol.92 (4), p.545-561

2022

Link zum Volltext

Verfügbarkeit prüfen

Syncytin‐1/HERV‐W envelope is an early activation marker of leukocytes and is upregulated in multiple sclerosis patients

European journal of immunology, 2020-05, Vol.50 (5), p.685-694

2020

Link zum Volltext

Verfügbarkeit prüfen

HERV-W envelope expression in blood leukocytes as a marker of disease severity of COVID-19

EBioMedicine, 2021-05, Vol.67, p.103363-103363, Article 103363

2021

Link zum Volltext

Verfügbarkeit prüfen

Fatal encephalopathy with wild‐type JC virus and ruxolitinib therapy

Annals of neurology, 2019-12, Vol.86 (6), p.878-884

2019

Link zum Volltext

Verfügbarkeit prüfen

Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial

Amyotrophic lateral sclerosis and frontotemporal degeneration, 2019-10, Vol.20 (7-8), p.595-604

2019

Link zum Volltext

Verfügbarkeit prüfen

Human endogenous retrovirus K contributes to a stem cell niche in glioblastoma

The Journal of clinical investigation, 2023-07, Vol.133 (13), p.1-18

2023

Link zum Volltext

Verfügbarkeit prüfen

TDP-43 proteinopathy in ALS is triggered by loss of ASRGL1 and associated with HML-2 expression

Nature communications, 2024-05, Vol.15 (1), p.4163-4163

2024

Link zum Volltext

Verfügbarkeit prüfen

Technical considerations in detection of HERV-K in amyotrophic lateral sclerosis: selection of controls and the perils of qPCR

Acta neuropathologica communications, 2019-07, Vol.7 (1), p.101-3, Article 101

2019

Link zum Volltext

Verfügbarkeit prüfen

SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression

Scientific reports, 2021-06, Vol.11 (1), p.12893-12893, Article 12893

2021

Link zum Volltext

Verfügbarkeit prüfen

The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity

PloS one, 2013-01, Vol.8 (1), p.e53623-e53623

2013

Link zum Volltext

Verfügbarkeit prüfen

Anti-human herpesvirus 6A/B IgG correlates with relapses and progression in multiple sclerosis

PloS one, 2014-08, Vol.9 (8), p.e104836-e104836

2014

Link zum Volltext

Verfügbarkeit prüfen

Study of the anti‐JCV antibody levels in a Spanish multiple sclerosis cohort

European journal of clinical investigation, 2017-02, Vol.47 (2), p.158-166

2017

Link zum Volltext

Verfügbarkeit prüfen

Human endogenous retrovirus HERV-Fc1 association with multiple sclerosis susceptibility: a meta-analysis

PloS one, 2014-03, Vol.9 (3), p.e90182-e90182

2014

Link zum Volltext

Verfügbarkeit prüfen

Role of the human endogenous retrovirus HERV-K18 in autoimmune disease susceptibility: study in the Spanish population and meta-analysis

PloS one, 2013-04, Vol.8 (4), p.e62090-e62090

2013

Link zum Volltext

Verfügbarkeit prüfen

Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in Madrid

Clinical neuropharmacology, 2017-01, Vol.40 (1), p.29-33

2017

Link zum Volltext

Verfügbarkeit prüfen

Human endogenous retrovirus-K (HML-2): a comprehensive review

Critical reviews in microbiology, 2018-11, Vol.44 (6), p.715-738

2018

Link zum Volltext

Verfügbarkeit prüfen

Human Herpesvirus 6 and Multiple Sclerosis: A One-Year Follow-up Study

Brain pathology (Zurich, Switzerland), 2006-01, Vol.16 (1), p.20-27

2006

Link zum Volltext

Verfügbarkeit prüfen

MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up

BMC neurology, 2012-09, Vol.12 (1), p.107-107, Article 107

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical parameters and HHV-6 active replication in relapsing—remitting multiple sclerosis patients

Journal of clinical virology, 2006-12, Vol.37, p.S24-S26

2006

Link zum Volltext

Verfügbarkeit prüfen

JC virus in cerebrospinal fluid samples of multiple sclerosis patients at the first demyelinating event

Multiple sclerosis, 2007-06, Vol.13 (5), p.590-595

2007

Link zum Volltext

Verfügbarkeit prüfen

Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive

Multiple sclerosis, 2007-06, Vol.13 (5), p.578-583

2007

Link zum Volltext

Verfügbarkeit prüfen

Environment–gene interaction in multiple sclerosis: Human herpesvirus 6 and MHC2TA

Human immunology, 2007-08, Vol.68 (8), p.685-689

2007

Link zum Volltext

Verfügbarkeit prüfen

Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis

Neurotherapeutics, 2022-07, Vol.19 (4), p.1085-1101

2022

Link zum Volltext

Verfügbarkeit prüfen

Multiple sclerosis retrovirus-like envelope gene: Role of the chromosome 20 insertion

BBA clinical, 2015-06, Vol.3, p.162-167

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 42

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(42)

Sprache

Englisch
(42)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Antibody Response to HML‐2 May Be Protective in Amyotrophic Lateral Sclerosis

Human Endogenous Retrovirus K Envelope in Spinal Fluid of Amyotrophic Lateral Sclerosis Is Toxic

Syncytin‐1/HERV‐W envelope is an early activation marker of leukocytes and is upregulated in multiple sclerosis patients

HERV-W envelope expression in blood leukocytes as a marker of disease severity of COVID-19

Fatal encephalopathy with wild‐type JC virus and ruxolitinib therapy

Safety and tolerability of Triumeq in amyotrophic lateral sclerosis: the Lighthouse trial

Human endogenous retrovirus K contributes to a stem cell niche in glioblastoma

TDP-43 proteinopathy in ALS is triggered by loss of ASRGL1 and associated with HML-2 expression

Technical considerations in detection of HERV-K in amyotrophic lateral sclerosis: selection of controls and the perils of qPCR

SMARCB1 deletion in atypical teratoid rhabdoid tumors results in human endogenous retrovirus K (HML-2) expression

The DNA copy number of human endogenous retrovirus-W (MSRV-type) is increased in multiple sclerosis patients and is influenced by gender and disease severity

Anti-human herpesvirus 6A/B IgG correlates with relapses and progression in multiple sclerosis

Study of the anti‐JCV antibody levels in a Spanish multiple sclerosis cohort

Human endogenous retrovirus HERV-Fc1 association with multiple sclerosis susceptibility: a meta-analysis

Role of the human endogenous retrovirus HERV-K18 in autoimmune disease susceptibility: study in the Spanish population and meta-analysis

Fingolimod Use for the Treatment of Multiple Sclerosis in a Clinical Practice Setting in Madrid

Human endogenous retrovirus-K (HML-2): a comprehensive review

Human Herpesvirus 6 and Multiple Sclerosis: A One-Year Follow-up Study

MHC2TA mRNA levels and human herpesvirus 6 in multiple sclerosis patients treated with interferon beta along two-year follow-up

Clinical parameters and HHV-6 active replication in relapsing—remitting multiple sclerosis patients

JC virus in cerebrospinal fluid samples of multiple sclerosis patients at the first demyelinating event

Human herpesvirus-6 and multiple sclerosis: relapsing-remitting versus secondary progressive

Environment–gene interaction in multiple sclerosis: Human herpesvirus 6 and MHC2TA

Retroviral Elements in Pathophysiology and as Therapeutic Targets for Amyotrophic Lateral Sclerosis

Multiple sclerosis retrovirus-like envelope gene: Role of the chromosome 20 insertion

Suchergebnisse filtern